[Corrected 9/22/15, 10:15am. See below.] Call it the Termeer trickle-down effect. Former Genzyme CEO Henri Termeer has been funding and advising Boston-area startups ever since his company was snapped up for $20 billion in 2011, bringing him a nine-digit payout. The latest startup to gain his imprimatur is Artax Biopharma, a Cambridge, MA-based startup working … Continue reading “With Termeer Aboard, Artax Tries New Attack On Autoimmune Disease”
Category: Boston
Rhone Obtains $5,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f501234c-3a76-4efd-8074-3dc005afcd94 Date 9/22/2015 Company Name Rhone Mailing Address 59 Grove Street New Canaan, CT 06840 USA Company Description As a group of busy professionals and passionate athletes, our team became perplexed by the tremendous gap in activewear. Rhone was created to fill that void, speaking directly to how men live, work, and … Continue reading “Rhone Obtains $5,000,000 Series A Financing Round”
TransMedics Receives $499,998 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0c7998da-fb55-484f-bc2c-52777555f521 Date 9/22/2015 Company Name TransMedics Mailing Address 200 Minuteman Road Andover, MA 01810 USA Company Description TransMedics has developed a revolutionary new system that enables living organ transplants. Website http://www.transmedics.com Transaction Type Venture Equity Transaction Amount $499,998 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Amount … Continue reading “TransMedics Receives $499,998 New Financing”
haystagg Lands $305,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4fd4cd89-1df7-47a7-ac0b-648c8c1f0354 Date 9/22/2015 Company Name haystagg Mailing Address 795 Elm Street Manchester, NH 03102 USA Company Description Our technology excels at making high-speed, real-time decisions. Computers do the heavy lifting. This allows for more complex decision-making at the time of the impression and removes the need for cookies, opening us up to … Continue reading “haystagg Lands $305,000 New Financing Round”
Kickstarting Entrepreneurs in San Diego by Testing Market Demand
In the six or seven years since Kickstarter and Indiegogo launched their crowdfunding sites, the way entrepreneurs raise money to finance their endeavors has fundamentally changed. These two companies have become the gold standard for helping entrepreneurs get their startups off the ground. In the old days (before 2008), an entrepreneur would typically come up … Continue reading “Kickstarting Entrepreneurs in San Diego by Testing Market Demand”
Kuvalanka Bolts Blueprint Medicines For COO Gig at Syros
Kyle Kuvalanka has been named the first chief operating officer of Cambridge, MA-based Syros Pharmaceuticals, a privately held startup developing so-called “gene control” drugs. Kuvalanka was previously the chief business officer of Blueprint Medicines (NASDAQ: [[ticker:BPMC]]), which went public and raised nearly $150 million in an IPO in April.
Announcing Xconomy Healthcare Summit—Nov. 17 at Broad Institute
It’s an old adage that there’s nothing more important than our health. Yet there’s hardly been a more contentious and complex issue in America in recent years than healthcare. For the past two years, Xconomy has held a special, invitation-only Healthcare Summit each fall in Boston to try to cut through the haze and rhetoric … Continue reading “Announcing Xconomy Healthcare Summit—Nov. 17 at Broad Institute”
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More
A little tip for you non-New Yorkers: September is the city’s best month of the year. The summer humidity starts giving way to fall crispness, tourist levels dissipate, the beaches clear out, and baseball and football seasons are in full swing (parking is still impossible but, shame on you for trying to drive here). Just … Continue reading “East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More”
With $75M, Deciphera Fuels Push For Cancer Drugs—And a Future IPO
In this recent boom of biotech IPOs, many startups have enlisted crossover investors—institutions that back both public and private companies—early in their lifecycle. It’s been a different story for Deciphera Pharmaceuticals, whose 12-year history includes moves from Massachusetts to Kansas and back. But regardless of the road it’s taken, Deciphera now finds itself joining the … Continue reading “With $75M, Deciphera Fuels Push For Cancer Drugs—And a Future IPO”
Deciphera Pharmaceuticals Secures $75,000,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cafb0ce3-ef59-4fc3-bbe2-371ee40a6379 Date 9/21/2015 Company Name Deciphera Pharmaceuticals Mailing Address 1601 Trapelo Road Waltham, MA 02451 USA Company Description Deciphera Pharmaceuticals, LLC was established in 2003 as a drug discovery and development company with the mission to design, optimize and introduce best-in-class small molecule switch inhibitors of protein kinases for human clinical trials … Continue reading “Deciphera Pharmaceuticals Secures $75,000,000 Series B Financing”
Alignable Obtains $8,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=05eb8ee5-b820-46e2-b3ff-5a4b2f10862e Date 9/21/2015 Company Name Alignable Mailing Address 1000 Winter Street Waltham, MA 02451 USA Company Description Alignable shifts the power to local businesses by giving them a place to network, market together, grow and support their communities. Website http://www.alignable.com Transaction Type Venture Equity Transaction Amount $8,000,000 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Alignable Obtains $8,000,000 New Funding Round”
At MIT, Commerce Secretary Recruits Techies, Pushes R&D Increase
With most of today’s political news coverage looking ahead to the 2016 presidential election, it’s easy to forget that the Obama administration still has more than a year left. The prospects are bleak for Congress to pass much of the president’s remaining agenda, but that doesn’t keep him and members of his cabinet from pushing … Continue reading “At MIT, Commerce Secretary Recruits Techies, Pushes R&D Increase”
Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy
There’s a lot of excitement these days about a type of cellular immunotherapy known as CAR-T, a method of modifying peoples’ immune cells to fight cancer. But you could also fill a book listing all the problems its makers will have to solve—how to test, manufacture, and even the define the nature of these cancer-killing … Continue reading “Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy”
MassChallenge Talks Global Expansion: 9 More Cities, 20,000 New Jobs
MassChallenge already calls itself the world’s largest accelerator, with more than 200 startups currently participating in its programs in Boston and London. And it’s only getting bigger. The Boston-based nonprofit, which also has a presence in Israel, plans to expand to nine more cities worldwide over the next five years. To help craft a cohesive … Continue reading “MassChallenge Talks Global Expansion: 9 More Cities, 20,000 New Jobs”
Kyruus Gets $25M More for “Moneyball” Approach to Doctors and Patients
[Updated, 1:40pm. See below] One of Boston’s most intriguing health IT startups just got a little richer. Kyruus, which makes analytics software for hospitals and health systems, has raised $25 million in new funding. By our count, that’s $56 million in total funding for Kyruus, which has 110 employees. [Updated figures from company representative—Eds.] The … Continue reading “Kyruus Gets $25M More for “Moneyball” Approach to Doctors and Patients”
Boston Tech Roundup: Flywire, DraftKings, Blade, & More
[Updated 9/17/15, 3:44 p.m. See below.] There has been a flurry of funding, acquisitions, hiring and firing, and other movement in the Boston-area startup scene over the past week or so. Time for a quick roundup of the latest local tech news: —PeerTransfer has changed its name to Flywire and moved into new digs overlooking … Continue reading “Boston Tech Roundup: Flywire, DraftKings, Blade, & More”
Former Auspex COO Named New Synlogic Prez
Cambridge, MA-based Synlogic, the synthetic biology startup developing “smart bug” drugs called synthetic biotics, has named Bharatt Chowrira its president. Chowrira was formerly the chief operating officer of Auspex Pharmaceuticals, which Teva Pharmaceutical Industries bought for over $3 billion in March. He’ll work alongside CEO and former Pfizer executive Jose-Carlos Gutierrez Ramos, who joined Synlogic … Continue reading “Former Auspex COO Named New Synlogic Prez”
Education in the Second Machine Age
We are in the early innings of a Second Machine Age—one relying on fewer people and more technology—yet we’re largely educating students for a bygone era. The (First) Machine Age, which is typically bracketed by the introduction of the automobile in the late 1880s and the invention of the transistor shortly after WWII, led to … Continue reading “Education in the Second Machine Age”
How NetBlazr, Webpass Court Cord-Cutters and Nibble Comcast’s Lunch
Sometimes what it takes to compete with a heavyweight is a series of small, methodical steps. At least, that’s the strategy that upstart wireless Internet service providers like NetBlazr and Webpass have chosen as they try to nibble off market share from Comcast and other huge incumbents in the cable, phone, and satellite industry. When … Continue reading “How NetBlazr, Webpass Court Cord-Cutters and Nibble Comcast’s Lunch”
Kyruus Secures $25,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35bed59c-f989-452a-bc30-f3dadb04bee3 Date 9/17/2015 Company Name Kyruus Mailing Address 600 Atlantic Avenue 20th Floor Boston, MA 02210 USA Company Description Kyruus has developed a software platform that includes professional profiles of doctors and big data analytics. Website http://www.kyruus.com Transaction Type Venture Equity Transaction Amount $25,000,000 Transaction Round Undisclosed Proceeds Purposes The funding will … Continue reading “Kyruus Secures $25,000,000 New Round”
Alector Raises $32M For Immune-Based Neuro Drug Development
Researchers around the world have explored the ties between the immune system and devastating neurodegenerative diseases such as Alzheimer’s. San Francisco biotech Alector wants to exploit those ties to make drugs, and today it announced $32 million in venture funding—with another round likely coming by year’s end—to continue that work. Alector was founded two years … Continue reading “Alector Raises $32M For Immune-Based Neuro Drug Development”
Young Entrepreneur Conference
The conference, organized by Babson College’s ETower group, aims to help “budding entrepreneurs” connect with and learn from startup veterans. Here’s more from the event organizer: “Attendees will hear from some of the most successful young entrepreneurs on how to launch and grow a business, including keynote speaker, Paul Liberman, Chief Operating Officer and Co-Founder of … Continue reading “Young Entrepreneur Conference”
Don’t Get Lost, Use Mapkin: Navigation App Taps Boston-Driver Wisdom
[Updated, 9/17/15. See below] Back-to-school traffic driving you crazy? Uber and taxi drivers going in circles? There’s a new mobile app that might help solve those problems (in the street, not the State House). It’s called Mapkin, and it’s basically trying to be a smarter, more personal GPS navigator. It also fits with the tech … Continue reading “Don’t Get Lost, Use Mapkin: Navigation App Taps Boston-Driver Wisdom”
Celgene Cozies up to Nurix With $150M Drug Development Deal
Celgene has established a reputation over the years for forming creative partnerships with nascent biotechs. Today it’s added another deal to that list, by taking an equity stake in a Bay Area startup called Nurix. Summit, NJ-based Celgene (NASDAQ: [[ticker:CELG]]) is paying Nurix $150 million up front and making an unspecified equity investment for an … Continue reading “Celgene Cozies up to Nurix With $150M Drug Development Deal”
The Risks and Opportunities of Doing Business in Emerging Markets
If you’re a startup or small business based in the U.S., chances are that you’re engaging with other emerging markets in some way or another. Perhaps you’re serving customers in those markets – or you have partners, suppliers, or consultants located there – or perhaps some of your team members are based there, or traveling … Continue reading “The Risks and Opportunities of Doing Business in Emerging Markets”
SynDevRx Obtains $9,093,899 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bcb3368f-20d5-4735-86db-181c2cba8806 Date 9/16/2015 Company Name SynDevRx Mailing Address One Broadway 14th Floor Cambridge, MA 02142 USA Company Description Our mission is to improve human health by developing polymeric prodrugs which deliver MetAP2 inhibitors to diseased tissues. The first two drug candidates we are developing have been previously shown to shrink tumors, inhibit … Continue reading “SynDevRx Obtains $9,093,899 New Financing Round”
Proteostasis Therapeutics Obtains $10,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b33df6ac-5407-4c3d-b2b2-78366217c0e1 Date 9/16/2015 Company Name Proteostasis Therapeutics Mailing Address 200 Technology Square 4th Floor Cambridge, MA 02139 USA Company Description Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s Proteostasis Network, which maintains the body’s natural protein homeostasis to protect us from numerous diseases. Website http://www.proteostasis.com … Continue reading “Proteostasis Therapeutics Obtains $10,000,000 New Funding”
Pronutria Secures $11,017,967 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a31c4788-59db-4503-bdbc-8dec62574b00 Date 9/16/2015 Company Name Pronutria Mailing Address 840 Memorial Drive 3rd Floor Cambridge, MA 02139 USA Company Description Pronutria created a revolutionary platform for identifying protein nutrients from within the human diet that have potent pharmacological effects, opening a vast untapped source of safe, breakthrough medicines. Website http://www.pronutria.com Transaction Type Venture … Continue reading “Pronutria Secures $11,017,967 New Funding”
SquadLocker Garners $2,250,000 Seed Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4d5c8a18-f1e1-44f6-bd94-dc7475c2ea92 Date 9/16/2015 Company Name SquadLocker Mailing Address 240 Bald Hill Rd. Warwick, RI 02886 USA Company Description At SquadLocker our mission is to deliver the ultimate customer experience. We recognize our customers’ satisfaction is the sum of many small details, as a company we look to deliver those details with individual … Continue reading “SquadLocker Garners $2,250,000 Seed Financing”
ProcessUnity Obtains $5,854,750 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=410fc8b3-9ea6-46b8-90de-ed2251a1b0dc Date 9/16/2015 Company Name ProcessUnity Mailing Address 33 Bradford Street Concord, MA 01742 USA Company Description ProcessUnity is a leading provider of cloud-based applications for risk management and service delivery management. The company’s software as a service (SaaS) platform gives organizations the control to assess, measure, and mitigate risk and to … Continue reading “ProcessUnity Obtains $5,854,750 New Financing Round”
Obama Nominates Duke Veteran Rob Califf To Lead FDA
President Obama has nominated cardiologist Rob Califf to be the next head of the Food and Drug Administration, replacing the outgoing Margaret “Peggy” Hamburg. The nomination is no surprise. Speculation that Califf could be the next commissioner gained momentum in late January when the FDA named him a top deputy. Two weeks later, Hamburg said … Continue reading “Obama Nominates Duke Veteran Rob Califf To Lead FDA”
LearnLaunch Accelerator Picks Startups in Games, Payments, & Books
The opportunities for new technology to improve education are much broader than assisting the core interactions between student, teacher, and subject matter. Edtech startups are trying to solve problems in everything from administrative operations to educational affordability. Boston’s LearnLaunch Accelerator is one example of the mix of ideas sprouting from the edtech industry. The organization … Continue reading “LearnLaunch Accelerator Picks Startups in Games, Payments, & Books”
Collaboration Platform Authorea Helps Ebola Virus Researchers, Others
[Updated, 9/16/15. See below.] Sometimes it takes many brilliant minds working together to create a breakthrough—such as understanding one of the most insidious viruses on the planet. Collaboration is a cornerstone of scientific and medical discoveries; the same might be said of New York-based Authorea, a platform for sharing and working together on research. Co-founders Alberto … Continue reading “Collaboration Platform Authorea Helps Ebola Virus Researchers, Others”
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.?
Americans need to spend less on healthcare. Anyone disagree? No country spends like we do: 17 percent of our gross domestic product the past four years, in fact, according to the World Bank. No other country—rich, poor, big, small, frozen, tropical, whatever—comes close. (OK, except for the tiny Pacific island nation of Tuvalu. Really.) Now … Continue reading “American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.?”
As Security Booms, Onapsis Gets Cash to Stop Corporate Cyber Attacks
Another day, another cybersecurity company to have on your radar—especially if you are concerned about things like corporate espionage, financial fraud, and international hackers stealing your intellectual property. These are huge problems, and Onapsis is trying to do something about it. Now, the Boston startup says it has raised $17 million in Series B funding, … Continue reading “As Security Booms, Onapsis Gets Cash to Stop Corporate Cyber Attacks”
ChoiceStream Secures $13,672,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=77c18f57-9fa8-4d2a-92e3-3d9a98454231 Date 9/15/2015 Company Name ChoiceStream Mailing Address 25 Drydock Ave. 5th Floor Boston, MA 02210 USA Company Description ChoiceStream develops personalization solutions for online consumer services, search services, e-retailers and iTV providers. Website http://www.choicestream.com Transaction Type Venture Equity Transaction Amount $13,672,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “ChoiceStream Secures $13,672,000 New Financing Round”
Qualcomm Buys Capsule to Unite Health Data Across Hospital & Home
Qualcomm (NASDAQ: [[ticker:QCOM]]) said its Qualcomm Life subsidiary has acquired Capsule Technologie, an Andover, MA-based healthtech systems company with more than 1,900 hospital customers in 38 countries. Financial terms of the deal were not disclosed. Qualcomm bought Capsule from JMI Equity and Bulger Capital Partners, which together held a majority ownership stake in the company … Continue reading “Qualcomm Buys Capsule to Unite Health Data Across Hospital & Home”
Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30
Jose-Carlos Gutierrez Ramos had one of biopharma’s plum jobs as a top Pfizer executive. So why did he give it up to take the risk of running a biotech startup in, of all things, the uncertain field of synthetic biology? You can ask Gutierrez-Ramos himself in a few weeks. He’s one of the stars of … Continue reading “Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30”
Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue
Time to add one more recipient of crossover investor cash to the list of official IPO candidates. Cambridge, MA-based Dimension Therapeutics just filed for an IPO this morning, aiming to raise cash from public investors to support a pipeline of potential gene therapies for hemophilia and rare diseases. Should the company go public, it’ll trade … Continue reading “Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue”
Led by Unica Founder, Allego Tackles Video Training for Salespeople
It can be cool to be a salesperson. Not only do you have expense accounts and work directly with customers, but you are on the cutting edge of where new software models hit the mainstream. Think software-as-a-service from Salesforce, inbound marketing from HubSpot, e-mail tracking with Yesware—and any number of customer relationship management tools such … Continue reading “Led by Unica Founder, Allego Tackles Video Training for Salespeople”
PureTech, Now Public, Names Ex-Biogen Exec MacLean New CFO
Boston-based PureTech has named Michael MacLean its new chief financial officer and executive vice president. MacLean was previously a finance executive at Iron Mountain (NYSE: [[ticker:IRM]]) and Biogen (NASDAQ: [[ticker:BIIB]]); at Biogen he also helped structure and manage a variety of deals and collaborations. PureTech, meanwhile, just raised nearly $200 million when it went public … Continue reading “PureTech, Now Public, Names Ex-Biogen Exec MacLean New CFO”
Plexxi Nabs $35M to Build Enterprise Data Fast Lanes
In today’s business world, the flood of software applications and humongous data sets that accompany them have put pressure on enterprise companies to figure out better ways to effectively manage the flow of all that information. These new challenges in data networking have given rise to new players taking aim at a market that has … Continue reading “Plexxi Nabs $35M to Build Enterprise Data Fast Lanes”
Pharma Plays The “Value” Card: Drug Spending Then And Now
Dr. John Lechleiter, the CEO of Eli Lilly, recently attempted to debunk five “Big Myths” about Big Pharma. As he wrote, “Only about 10 cents of every U.S. healthcare dollar is spent on retail prescription medicines—which is the same share that was spent on prescriptions in 1960. While the overall use of medicines to treat … Continue reading “Pharma Plays The “Value” Card: Drug Spending Then And Now”
Plexxi Secures $35,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a7d39b19-898c-42fa-8471-b376b16cfdab Date 9/14/2015 Company Name Plexxi Mailing Address 100 Innovative Way Nashua, NH 03062 USA Company Description The network must evolve. Connecting what you want, where you want, and how you want – without the complexity, rigidity, and fragility of traditional hierarchical networks – is just the beginning of a whole new … Continue reading “Plexxi Secures $35,000,000 New Funding”
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More
Guess what? Though this may have been forgotten amidst the biotech boom, drug trials often fail. This week offered a reminder of that, as investors hammered a few Boston-area biotech stocks after disappointing data. The news wasn’t all bad, though. Akebia Therapeutics (NASDAQ: [[ticker:AKBA]]) surged on some positive mid-stage results. Some deals were made. A … Continue reading “East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More”
SciAps Garners $4,300,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=50a957a4-bd6f-4dba-91f8-067c79593ef3 Date 9/11/2015 Company Name SciAps Mailing Address 2 Constitution Way Woburn, MA 01801 USA Company Description SciAps, Inc., is a Boston-based instrumentation company specializing in portable analytical instruments. Our mission is to provide durable, field-tested, portable instruments to identify any compound, any mineral, any element — anyplace on the planet. Website … Continue reading “SciAps Garners $4,300,000 New Funding Round”
DOTS Devices Obtains $8,012,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24e31c3c-c52b-4ab4-8b6b-266f0da5e8a0 Date 9/11/2015 Company Name DOTS Devices Mailing Address 2 Mercer Street Natick, MA 01760 USA Company Description DOTS is developing technology that would be used for rapid, on-the-spot detection of allergens, including food allergens. Website Undisclosed Transaction Type Venture Equity Transaction Amount $8,012,000 Transaction Round Series A Proceeds Purposes Proceeds purposes … Continue reading “DOTS Devices Obtains $8,012,000 Series A Financing”
Solx Receives $2,250,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f3fb686d-b4c2-4526-8085-05e066f2c01b Date 9/11/2015 Company Name Solx Mailing Address 230 Second Ave. Waltham, MA 02451 USA Company Description The SOLX Glaucoma Treatment System is the next generation treatment platform that has the potential to change the current approach to glaucoma therapy. Website http://www.solx.com Transaction Type Debt Transaction Amount $2,250,000 Transaction Round Undisclosed Proceeds … Continue reading “Solx Receives $2,250,000 New Funding”
Nipro Acquires InfraReDx for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eb1b549d-170b-4589-9003-866268401519 Date 9/11/2015 Company Name InfraReDx Mailing Address 34 Third Avenue Burlington, MA 01803 USA Company Description The company has now developed a fiber-optic, catheter-based, near infrared (NIR) spectroscopy system designed to characterize the composition of coronary plaques in patients undergoing catheterization. This NIR system is currently being evaluated in a clinical … Continue reading “Nipro Acquires InfraReDx for Undisclosed Sum”
MassChallenge Touts Gender Diversity Stats As Wider Dialogue Builds
Lalita Booth is the CEO of a six-person startup, Navitome, which includes two women and four men. But such is the state of the tech industry that sometimes when she walks into a room for a business meeting, she said, people on the other side of the table look at her male colleagues and ask … Continue reading “MassChallenge Touts Gender Diversity Stats As Wider Dialogue Builds”